VANI · Vivani Medical, Inc. · Executive Compensation
$1.25
+0.02 (+1.63%)
At close · Oct 5
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions and events raise substantial doubt about our ability to continue as a going concern within one year after the date these condensed consolidated financial statements are issued. ... Because these plans are not fully within our control and their successful execution cannot be considered certain, management has concluded that its plans do not alleviate the substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$111.85M
Shares
90.20M
Volume · Oct 5
76.07K
Avg daily vol (3M)
456.47K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Adam Mendelsohn | Chief Executive Officer | $877,580 |
| Truc Le | Chief Operating Officer | $696,864 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Adam Mendelsohn | Chief Executive Officer | $1,084,200 |
| Truc Le | Chief Operating Officer | $862,600 |
| Lisa Porter | Chief Medical Officer | $678,200 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Adam Mendelsohn | Chief Executive Officer | $1,044,621 |
| Lisa Porter | Chief Medical Officer | $661,533 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Scott Dunbar | Former Chief Executive Officer | $382,153 |
| Truc Le | Chief Operating Officer | $337,200 |
| Adam Mendelsohn | Chief Executive Officer | $312,014 |
| Brigid A. Makes | Chief Financial Officer | $306,009 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Truc Le | Chief Operating Officer | $552,674 |
| Adam Mendelsohn | Chief Executive Officer | $308,300 |
| Scott Dunbar | Former Chief Executive Officer | $305,685 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Alexandra Popoff | Director | Appointed | 2026-06-30 |
| August Moretti | Director | Appointed | 2026-06-30 |
| Adam Mendelsohn | Director | Appointed | 2026-06-30 |
| Daniel Bradbury | Director | Appointed | 2026-06-30 |
| Aaron Mendelsohn | Director | Appointed | 2026-06-30 |
| Gregg Williams | Director | Appointed | 2026-06-30 |
| Anthony Baldor | Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer | Appointed | 2025-06-11 |
| Daniel Bradbury | Director | Appointed | 2024-03-06 |
| Scott Dunbar | named executive officer in the Company's 2023 proxy statement and former Acting Chief Executive Officer of the Company's predece | Terminated | 2023-11-24 |
| Adam Mendelsohn | director | Appointed | 2022-09-02 |
| Truc Le | Chief Operating Officer | Appointed | 2022-09-02 |
| Donald Dwyer | Chief Business Officer | Appointed | 2022-09-02 |
| Lisa Porter | Chief Medical Officer | Appointed | 2022-09-02 |
| Edward Sedo | Acting Chief Accounting Officer | Resigned | 2022-09-02 |
| Adam Mendelsohn | Chief Executive Officer | Appointed | 2022-09-02 |
| Brigid A. Makes | Chief Financial Officer | Appointed | 2022-09-02 |
| Scott Dunbar | Acting Chief Executive Officer | Resigned | 2022-09-02 |
| Matthew Pfeffer | director | Resigned | 2022-09-02 |
| Jonathan Will McGuire | director | Resigned | 2022-09-02 |
| Edward Randolph | Chief Operating Officer | Resigned | 2022-08-05 |